Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center
- PMID: 31642024
- DOI: 10.1007/s11060-019-03317-6
Analysis of intra-operative variables as predictors of 30-day readmission in patients undergoing glioma surgery at a single center
Abstract
Purpose: Reducing the time from surgery to adjuvant chemoradiation, by decreasing unnecessary readmissions, is paramount for patients undergoing glioma surgery. The effects of intraoperative risk factors on 30-day readmission rates for such patients is currently unclear. We utilized a predictive model-driven approach to assess the impact of intraoperative factors on 30-day readmission rates for the cranial glioma patient.
Methods: Retrospectively, the intraoperative records of 290 patients who underwent glioma surgery at a single institution by a single surgeon were assessed. Data on operative variables including anesthesia specific factors were analyzed via univariate and stepwise regression analysis for impact on 30-day readmission rates. A predictive model was built to assess the capability of these results to predict readmission and validated using leave-one-out cross-validation.
Results: In multivariate analysis, end case hypothermia (OR 0.28, 95% CI [0.09, 0.84]), hypertensive time > 15 min (OR 2.85, 95% CI [1.21, 6.75]), and pre-operative Karnofsky performance status (KPS) (OR 0.63, 95% CI [0.41, 0.98] were identified as being significantly associated with 30-day readmission rates (chi-squared statistic vs. constant model 25.2, p < 0.001). Cross validation of the model resulted in an overall accuracy of 89.7%, a specificity of 99.6%, and area under the receiver operator curve (AUC) of 0.763.
Conclusion: Intraoperative risk factors may help risk-stratify patients with a high degree of accuracy and improve postoperative patient follow-up. Attention should be paid to duration of hypertension and end-case final temperature as these represent potentially modifiable factors that appear to be highly associated with 30-day readmission rates. Prospective validation of our model is needed to assess its potential for implementation as a screening tool to identify patients undergoing glioma surgery who are at a higher risk of post-operative readmission within 30 days.
Keywords: Cranial; Glioma; Hospital readmission; Neurosurgery; Predictive modeling.
Similar articles
-
Costs and Complications Associated With Resection of Supratentorial Tumors With and Without the Operative Microscope in the United States.World Neurosurg. 2020 Jun;138:e607-e619. doi: 10.1016/j.wneu.2020.03.021. Epub 2020 Mar 30. World Neurosurg. 2020. PMID: 32171932 Free PMC article.
-
Development and validation of a predictive model for 90-day readmission following elective spine surgery.J Neurosurg Spine. 2018 Sep;29(3):327-331. doi: 10.3171/2018.1.SPINE17505. Epub 2018 Jun 15. J Neurosurg Spine. 2018. PMID: 29905519
-
Factors triggering an additional resection and determining residual tumor volume on intraoperative MRI: analysis from a prospective single-center registry of supratentorial gliomas.Neurosurg Focus. 2016 Mar;40(3):E4. doi: 10.3171/2015.11.FOCUS15542. Neurosurg Focus. 2016. PMID: 26926062
-
Perioperative risk factors associated with unplanned neurological intensive care unit readmission following elective supratentorial brain tumor resection.J Neurosurg. 2022 Dec 2;139(2):315-323. doi: 10.3171/2022.10.JNS221318. Print 2023 Aug 1. J Neurosurg. 2022. PMID: 36461816
-
Incidence and predictors of 30-day readmission for patients discharged home after craniotomy for malignant supratentorial tumors in California (1995-2010).J Neurosurg. 2014 May;120(5):1201-11. doi: 10.3171/2014.1.JNS131264. Epub 2014 Mar 7. J Neurosurg. 2014. PMID: 24605840
Cited by
-
Dihydrotanshinone I inhibits human glioma cell proliferation via the activation of ferroptosis.Oncol Lett. 2020 Oct;20(4):122. doi: 10.3892/ol.2020.11980. Epub 2020 Aug 13. Oncol Lett. 2020. PMID: 32863935 Free PMC article.
-
Thirty-Day Unplanned Readmission After Ambulatory Laparoscopic Cholecystectomy in Western China: A Retrospective Study.Cureus. 2021 Mar 16;13(3):e13932. doi: 10.7759/cureus.13932. Cureus. 2021. PMID: 33868863 Free PMC article.
-
Development of a Clinical Decision Support System to Predict Unplanned Cancer Readmissions.AMIA Annu Symp Proc. 2023 Apr 29;2022:1173-1180. eCollection 2022. AMIA Annu Symp Proc. 2023. PMID: 37128456 Free PMC article.
-
Effects of Anesthesia on Postoperative Recurrence and Metastasis of Malignant Tumors.Cancer Manag Res. 2020 Aug 24;12:7619-7633. doi: 10.2147/CMAR.S265529. eCollection 2020. Cancer Manag Res. 2020. PMID: 32922072 Free PMC article. Review.
-
Unplanned 30-Day Readmission in Glioblastoma Patients: Implications for the Extent of Resection and Adjuvant Therapy.Cancers (Basel). 2023 Aug 1;15(15):3907. doi: 10.3390/cancers15153907. Cancers (Basel). 2023. PMID: 37568723 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources